menu
Over 115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharmaceutical drug / therapy products, claims Roots Analysis
Despite the fact thatbiopharmaceuticals offer significant profit margins, innovator companies areplagued by high costs of development, complex production protocols and specialprocedures and equipment for fill / finish operations. Consequently, a numberof drug manufacturers have demonstrated a preference for outsourcing fill /finish operations of such products.

Despite the fact thatbiopharmaceuticals offer significant profit margins, innovator companies areplagued by high costs of development, complex production protocols and specialprocedures and equipment for fill / finish operations. Consequently, a numberof drug manufacturers have demonstrated a preference for outsourcing fill /finish operations of such products.

 

To order this 480+ page report, which features 350+ figuresand 260+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

 

The USD 4.2 billion(by 2030) financial opportunity within the biologics fill / finish services markethas been analyzed across the following segments:

§ Types of PrimaryPackaging Containers

§ Ampoules

§ Cartridges

§ Syringes

§ Vials

 

§ Types of Biologics

§ Peptides / proteins

§ Antibodies

§ Vaccines

§ Cell therapies

§ Gene therapies

§ Viral products

§ Oligonucleotides

§ Others

 

§ Company Size

§ Small-sized

§ Mid-sized

§ Large / very large

 

§ Scale of Operation

§ Preclinical

§ Clinical

§ Commercial

 

§ Key Therapeutic Areas

§ Cancer

§ Infectious diseases

§ Autoimmune diseases

§ Cardiovasculardiseases

§ Other indications

 

§ Key GeographicalRegions

§ North America (US,Canada)

§ Europe (UK, France,Germany, Italy, Spain and rest of the Europe)

§ Asia-Pacific (Japan,China, South Korea, India and Australia)

 

The BiologicsFill / Finish Services Market, 2019-2030.” report features the following companies, which weidentified to be key players in this domain:

§  Advanced BioScience Laboratories (ABL)

§  Albany Molecular Research (AMRI)

§  Biocon

§  BioPharma Solutions

§  BioReliance

§  Boehringer Ingelheim BioXcellence

§  ChemPartner

§  Emergent BioSolutions

§  IDT Biologika

§  Lonza

§  LuinaBio

§  Mycenax Biotech

§  Patheon

§  Recipharm

§  Vetter Pharma

§  WuXi Biologics

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction

4. Competitive Landscape

5. Company Competitiveness Analysis

6. Biologics Fill / Finish Service Providers in NorthAmerica: Company Profiles

7. Biologics Fill / Finish Service Providers in Europe:Company Profiles 

8. Biologics Fill / Finish Service Providers inAsia-Pacific: Company Profiles

9. Partnerships and Collaborations

10. Recent Expansions

11. Capacity Analysis

12. Demand Analysis

13. Biologics Manufacturing and Fill / Finish: KeyPerformance Indicator Analysis

14. Market Sizing and Opportunity Analysis

 

15. Future Growth Opportunities

 

16. Case Study: Robotic Systems in Fill / Finish Operations

 

17. Case Study: Ready-to-Use Packaging Components inAseptic Fill / Finish Operations

 

18. Conclusion

 

19. Interview Transcripts

 

20. Appendix 1: Tabulated Data

 

21. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com